Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |